HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$2.44
Day range
$2.39 - $2.45
Year range
$1.90 - $6.08
Market cap
219.35M USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 15.33M | 92.10% |
Operating expense | 12.32M | -21.40% |
Net income | -13.27M | 41.67% |
Net profit margin | -86.59 | 69.64% |
Earnings per share | -0.16 | 50.15% |
EBITDA | -11.52M | 45.91% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 66.33M | -9.38% |
Total assets | 138.25M | 4.73% |
Total liabilities | 82.62M | 17.09% |
Total equity | 55.63M | — |
Shares outstanding | 90.27M | — |
Price to book | 3.94 | — |
Return on assets | -24.07% | — |
Return on capital | -27.51% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.27M | 41.67% |
Cash from operations | -17.97M | -47.66% |
Cash from investing | -367.00K | 98.65% |
Cash from financing | 26.77M | 13,690.86% |
Net change in cash | 8.44M | 121.39% |
Free cash flow | -17.42M | -387.10% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
188
